Innocenti Francesca, Lazzari Cristian, Ricci Francesca, Paolucci Elisa, Agishev Ilya, Pini Riccardo
Emergency Department High-Dependency Unit, Department of Clinical and Experimental Medicine, Careggi University Hospital, Florence, Italy.
Open Access Emerg Med. 2021 Nov 11;13:465-479. doi: 10.2147/OAEM.S238696. eCollection 2021.
In the Emergency Medicine setting, D-dimer is currently employed in the diagnostic assessment of suspected venous thromboembolism and aortic syndrome. The nonspecific symptoms reported by patients, like chest pain, dyspnea or syncope, uncover a wide range of differential diagnosis, spanning from mild to life-threatening conditions. Therefore, we assumed the perspective of the Emergency Physician and, in this narrative review, we reported a brief presentation of the epidemiology of these symptoms and the characteristics of patients, in whom we could suspect the aforementioned pathologies. We also reported in which patients D-dimer gives useful information. In fact, when the probability of the disease is high, the D-dimer level is futile. On the contrary, given the low specificity of the test, when the probability of the disease is very low, a false-positive value of the D-dimer only increases the risk of overtesting. Patients with low to moderate probability really benefit from the D-dimer testing, in order to prevent the execution of expensive and potentially dangerous imaging tests. In the second part of the review, we focused on the prognostic value of the test in septic patients. The early prognostic stratification of septic patients remains a challenge for the Emergency Physician, in the absence of a definite biomarker or score to rely on. Therefore, we need several parameters for the early identification of patients at risk of an adverse prognosis and the D-dimer may play a role in this demanding task. SARS COVID-19 patients represent an emerging reality, where the role of the D-dimer for prognostic stratification could be relevant. In fact, in patients with severe forms of this disease, the D-dimer reaches very high values, which appear to parallel the course of respiratory failure. Whether the test may add useful information for the management of these patients remains to be determined.
在急诊医学环境中,D - 二聚体目前用于疑似静脉血栓栓塞和主动脉综合征的诊断评估。患者报告的非特异性症状,如胸痛、呼吸困难或晕厥,揭示了广泛的鉴别诊断范围,涵盖从轻度到危及生命的疾病。因此,我们从急诊医生的角度出发,在这篇叙述性综述中,简要介绍了这些症状的流行病学以及我们可能怀疑上述疾病的患者特征。我们还报告了D - 二聚体在哪些患者中能提供有用信息。事实上,当疾病概率较高时,D - 二聚体水平并无用处。相反,鉴于该检测的低特异性,当疾病概率非常低时,D - 二聚体的假阳性值只会增加过度检测的风险。低至中度概率的患者确实能从D - 二聚体检测中受益,以避免进行昂贵且可能有风险的影像学检查。在综述的第二部分,我们聚焦于该检测在脓毒症患者中的预后价值。在缺乏明确的生物标志物或评分可依赖的情况下,脓毒症患者的早期预后分层对急诊医生来说仍然是一项挑战。因此,我们需要多个参数来早期识别有不良预后风险的患者,而D - 二聚体可能在这项艰巨任务中发挥作用。新型冠状病毒肺炎(SARS COVID - 19)患者是一个新出现的情况,其中D - 二聚体在预后分层中的作用可能具有相关性。事实上,在这种疾病的重症患者中,D - 二聚体达到非常高的值,这似乎与呼吸衰竭的病程平行。该检测是否能为这些患者的管理增加有用信息仍有待确定。